Surya Life Sciences Limited - chemicals and materials in Navi Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24230MH2005PLC154467 Incorporated 04 July 2005 ROC Mumbai HQ Navi Mumbai, Maharashtra, India
Active Public Limited Company chemicals and materials MSME · Medium
Revenue · FY 2025
₹118.61 Cr
▲ 12% YoY
Net profit · FY 2025
₹5.17 Cr
Net margin 4.4%
EBITDA · FY 2025
₹11.34 Cr
EBITDA margin 9.6%
Authorised capital
₹6.1 Cr
Registered with MCA
Paid-up capital
₹5.99 Cr
Issued & subscribed
Open charges
₹39.5 Cr
Satisfied ₹52.61 Cr
Company age
21 yrs
Est. 2005
Employees · EPFO
40
Provident fund records

About Surya Life Sciences Limited

Data last updated:

Surya Life Sciences Limited is a public limited company based in Navi Mumbai, Maharashtra, India. It operates in the aromatics and benzene derivatives segment of the chemicals and materials sector. It was incorporated on 04 July 2005 and has been in existence for over 21 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2005PLC154467. Its GSTIN is 24AAJCS3126R1ZX (Gujarat). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹6.1 Cr and a paid-up capital of ₹5.99 Cr. It is led by directors including Neha Yash Joshi and Arun Durgaprasad Joshi.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 206 Radhamit Society Plot No 33 Sector 18 Nerul West, Navi Mumbai, Maharashtra, India – 400706.

As per the financials filed for FY 2025, the company reported a revenue of ₹118.61 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹5.17 Cr (net margin 4.4%) and EBITDA of ₹11.34 Cr (EBITDA margin 9.6%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 14% over five years.

The company has about 40 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹39.5 Cr and satisfied charges of ₹52.61 Cr on record. Court records list 2 cases involving the company, including 2 filed against it; 1 case is pending. The company has 4 deals on record (3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹5.76 Cr; the latest was in December 2022. Its 8 peer companies in the Chemicals industry (API Manufacturers, Aromatics), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Kimia Biosciences Limited with revenue of ₹120.24 Cr.

Surya Life Sciences Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-06-0002250). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website suryalifesciences.com.

Company details

CIN U24230MH2005PLC154467
Registration Number 154467
Incorporation Date 04 July 2005
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-GJ-06-0002250

CIN history

Surya Life Sciences has one previous CIN (Corporate Identification Number): U24230MH2005PTC154467. The current CIN is U24230MH2005PLC154467, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24230MH2005PLC154467Current
U24230MH2005PTC154467Previous

Recognitions & Rankings of Surya Life Sciences

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-GJ-06-0002250

Contact details

Surya Life Sciences Limited's registered office is in Navi Mumbai, Maharashtra. Its website is suryalifesciences.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    B – 206 Radhamit Society Plot No 33 Sector 18 Nerul West, Navi Mumbai, Maharashtra, India – 400706
  • Industry
    Chemicals and Materials, Aromatics & Benzene Derivatives

To see the full contact details of Surya Life Sciences Limited, buy the company report.

Comprehensive company report
Surya Life Sciences Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Surya Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Surya Life Sciences Limited, buy the company report.

Financials of Surya Life Sciences Limited

FY 2025 filings available

Surya Life Sciences Limited reported revenue of ₹118.61 Cr (up 12% YoY) for FY 2025.

Revenue · FY 2025
₹118.61 Cr ▲ 12%
Net profit · FY 2025
₹5.17 Cr margin 4.4%
EBITDA · FY 2025
₹11.34 Cr margin 9.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 12%
3 years · compounded
▲ 6%
5 years · compounded
▲ 14%
EBITDA CAGR growth
1 year
▲ 90%
3 years · compounded
▲ 42%
5 years · compounded
▲ 24%

Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 12% growth in the latest year. EBITDA rose 90% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹11.34 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹5.17 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin9.6%
Net Profit Margin4.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Surya Life Sciences Limited, buy the company report.

Board of directors of Surya Life Sciences Limited

Surya Life Sciences has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Neha Yash JoshiDirector16 Feb 20224 Years 9 MonthsCurrent
Arun Durgaprasad JoshiDirector04 Jul 200521 Years 4 MonthsCurrent
Sandhya Arunbhai JoshiDirector04 Jul 200521 Years 4 MonthsCurrent
Yash Arun JoshiDirector04 Jul 200521 Years 4 MonthsCurrent

Peer comparison

Surya Life Sciences Limited is compared with the 8 companies closest to it by revenue in the Chemicals industry (API Manufacturers, Aromatics), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Kimia Biosciences Limited₹120.24 Cr (FY 2025)13.0%Gurgaon, Haryana, India
Galaxy Laboratories Private Limited₹120.18 Cr (FY 2025)17.0%Aurangabad, Maharashtra, India
Vartika Chemicals & Pharmaceuticals Private Limited₹120.07 Cr (FY 2025)-17.0%New Delhi, Delhi, India
Virchow Chemicals Pvt. Ltd.₹120.01 Cr (FY 2020)-26.0%Hyderabad, Telangana, India
Surya Life Sciences Limitedthis company₹118.61 Cr (FY 2025)₹5.17 Cr4.4%12.0%40Navi Mumbai, Maharashtra, India
Lactose (India) Limited₹117.85 Cr (FY 2025)2.0%Poicha, Gujarat, India
Prachem Laboratories Private Limited₹117.4 Cr (FY 2025)-6.0%Gandhinagar, Gujarat, India
Shree Balaji Aromatics Private Limited₹115.95 Cr (FY 2025)-1.0%Uttar Pradesh, India
Aastrid Life Sciences Private Limited₹115.25 Cr (FY 2025)6.0%Navi Mumbai, Maharashtra, India

To see the full peer comparison of Surya Life Sciences Limited, buy the company report.

Auditor

Surya Life Sciences Limited is audited by SHAH AKSHAY & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
SHAH AKSHAY & ASSOCIATESFY 2023143258W

Shareholding

The shareholding of Surya Life Sciences Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Surya Life Sciences Limited, buy the company report.

Charges & borrowings

Open charges
₹39.5 Cr
Satisfied charges
₹52.61 Cr
Breakdown by lending institutions
Others₹39.50 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
07 Nov 2023100810655Others₹29.5 CrOpen
03 Nov 2023100810685Others₹10 CrOpen
24 Mar 2023100698238Axis Bank Limited₹2 CrSatisfied
22 Oct 2020100387337Axis Bank Limited₹19.76 LakhSatisfied
11 Jan 2019100235318Axis Bank Limited₹7.29 LakhSatisfied

To see the full charge records of Surya Life Sciences Limited, buy the company report.

Total charge records: 8 View all charges

Deals & funding

Surya Life Sciences Limited has 4 deals on record (3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹5.76 Cr; the latest was in December 2022.

Total deals
4
Funding rounds
3
Secondary share transfer
1
Disclosed funding
₹5.76 Cr

Deals on record (4 of 4)

WhenDealAmountParties
Dec 2022Secondary share transferUndisclosedBuyer: an individual
Seller: 3 individuals
Mar 2016Funding round₹2.45 CrInvestors: 2 individuals
Mar 2014Funding round₹1.13 CrInvestors: 4 individuals
Mar 2012Funding round₹2.18 CrInvestors: Surya Remedies Private Limited , 3 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Surya Life Sciences Limited was last rated by Icra on 04 Dec 2020.

Rating agencyRated onRating
Icra04 Dec 2020

To see the full credit ratings and regulatory alerts of Surya Life Sciences Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Surya Life Sciences Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Surya Life Sciences Limited has a workforce of 40 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
40
Active EPFO establishments
1
Employee growth
-23.1%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2740
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Surya Life Sciences Limited, buy the company report.

GST

Surya Life Sciences has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
24AAJCS3126R1ZXGujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Surya Life Sciences Limited, buy the company report.

Recent activity

Surya Life Sciences Limited has 5 board changes on record since 2005: 4 appointments and 1 cessation. The latest: Neha Yash Joshi was appointed as Director on 16 Feb 2022.

Charges
A charge registered on 24 Mar 2023 via Charge ID 100698238 with Axis Bank Limited was fully satisfied on 20 Nov 2025.
Charges
A charge registered on 11 Jan 2019 via Charge ID 100235318 with Axis Bank Limited was fully satisfied on 17 Nov 2025.
Charges
A charge registered on 22 Oct 2020 via Charge ID 100387337 with Axis Bank Limited was fully satisfied on 12 Nov 2025.
AGM
Surya Life Sciences Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge registered on 27 Nov 2012 via Charge ID 10389896 with Axis Bank Limited was fully satisfied on 11 Jun 2025.
Charges
A charge registered on 16 Oct 2012 via Charge ID 10383817 with Axis Bank Limited was fully satisfied on 11 Jun 2025.
Charges
A charge with Others of Rs. 29.50 Cr registered on 07 Nov 2023 with Charge ID 100810655 was modified on 08 May 2025.
Filing
Surya Life Sciences Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Charges
A charge with Others amounted to Rs. 29.50 Cr with Charge ID 100810655 was registered on 07 Nov 2023.
Charges
A charge with Others amounted to Rs. 10.00 Cr with Charge ID 100810685 was registered on 03 Nov 2023.
Charges
A charge with Axis Bank Limited amounted to Rs. 2.00 Cr with Charge ID 100698238 was registered on 24 Mar 2023.
Charges
A charge with Axis Bank Limited of Rs. 22.69 Cr registered on 16 Oct 2012 with Charge ID 10383817 was modified on 17 Dec 2022.

13 earlier events are in the company report.

Frequently asked questions

Surya Life Sciences is an active public limited company based in Navi Mumbai, Maharashtra, India. The company works in aromatics and benzene derivatives, within the chemicals and materials industry. It was incorporated on 04 July 2005 (21+ years old) and is registered under CIN U24230MH2005PLC154467.

Surya Life Sciences has 4 current directors:

The latest financial statements of Surya Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Surya Life Sciences is 24AAJCS3126R1ZX, registered in Gujarat. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Surya Life Sciences is U24230MH2005PLC154467. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Surya Life Sciences has 2 court cases on record: 2 filed against it. 1 is pending.

Surya Life Sciences was incorporated on 04 July 2005, making it 21+ years old. It is registered with the Registrar of Companies, Mumbai.

Surya Life Sciences has 4 deals on record (3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹5.76 Cr; the latest was in December 2022.

The peers of Surya Life Sciences by revenue are Kimia Biosciences Limited, Galaxy Laboratories Private Limited, Vartika Chemicals & Pharmaceuticals Private Limited, Virchow Chemicals Pvt. Ltd, Lactose (India) Limited and 3 more, all in the Chemicals industry (API Manufacturers, Aromatics), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Neha Yash Joshi was appointed as Director on 16 Feb 2022. Priti Arun Joshi ceased to be Director on 18 Oct 2012. Arun Durgaprasad Joshi was appointed as Director on 04 Jul 2005. Surya Life Sciences has 5 board changes on record in total.

Yes, Surya Life Sciences is registered as a medium enterprise under Udyam registration (number: UDYAM-GJ-06-0002250).